GRG Research Interests

In our lab we mainly focus on drug discovery and development of various therapeutic targets such as Neurodegenerative Disorders (ALS, Alzheimer’s and Parkinson’s disease etc.), and Inflammatory Disorders (COPD, RA), GPCRs for the treatment of Diabetic Disorders (NIDDM), Cancer, Cardiovascular Disorders, Obesity, and other Metabolic Disorders.   We are also very interested in research and development with an emphasis in design and synthesis of both symmetric and asymmetric orga...
More

Projects

Novel Ghrelin Antagonists for treatment of Obesity. Novel Sigma-1 Receptor Agonists for treatment of Neurodegenerative Diseases. Novel A2A Adenosine Receptor Antagonists for the Treatment of Parkinson’s disease and SAR of the new Preladenant analogs. Discovery of novel Excitatory Amino Acid Transporter-2 (EAAT2) modulators for the treatment of ALS and other neurodegenerative disorders. Regulation of cancer cell metabolism: Targeting cancer metabolism as an alternative therapeutic trea...
More

Patents & Publications

"Induction of Heme Oxygenase I (HMOX1) by HPP-4382: A novel modulator of Bach-1 activity”; Otis Attucks, Kimberly Jasmer, Mark Hannink, Jareer Kassis, Zhenping Zhong, Suparna Gupta, Sam Victory, Mustafa Guzel, Dharma Polisetti, Robert Andrews, Adnan Mjalli, and Matthew Kostura; PLoSOne, 9, 7, (2014), p:1-12, e101044. "Synthesis of Azabridged Bicyclic Ring Systems by Intramolecular Sakurai Reactions"; Mustafa Guzel, Robert Smitherman, and Sezgin Kiren; Tetrahedron Letters, manuscript sub...
More